IBEX
IBEX's revenue rose 15.4% to $644 million in fiscal 2026. Its operating margin was 8.5%, up from 8.3% a year earlier. Free cash flow was $31 million, up 14.3%. It paid out $14 million in dividends and buybacks, 46% of free cash flow. The diluted share count fell 5.8%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What IBEX does
IBEX runs customer service operations for other companies. It answers their customers' questions, gives technical support, sells upgrades and add-ons on their behalf, and handles back-office work such as finance, accounting and human resources administration. It works across phone, email, chat, text messages and social media, for about 140 clients in retail and e-commerce, health technology, telecommunications, financial technology, travel and technology, from fast-growing online brands to large established companies.
Its Connect business, the customer service work, brings in most of its revenue. It also offers Wave iX, a set of artificial intelligence (AI) tools such as virtual agents and live translation that it manages alongside human agents, and ibex Digital, which helps clients win new customers through digital marketing and e-commerce technology. It typically starts with one service at one center and then aims to add services and locations for the same client.
IBEX operates 30 delivery centers in the United States, the Philippines, Jamaica, Nicaragua, Pakistan and Honduras, with about 35,000 employees at June 30, 2026, and 97% of its on-site capacity is outside the continental United States. One of its shareholders, The Resource Group International, must consent to certain company actions.
Its biggest risks, as it describes them
- Its dependence on a small number of key clients, who could leave, consolidate or bring the work in-house.
- Disruption to its operations in the Philippines, Jamaica, Pakistan and Nicaragua, where most of its staff work.
- Strong competition, and the need to keep up as AI changes how customer service is delivered.
- Failing to attract, keep and motivate enough agents and managers.
- Swings against the US dollar in the currencies of the countries where it operates.
Income statement
From fiscal 2021 to 2026, earnings per share grew 34.5% a year and net income 28.7% a year, as buybacks cut the share count by 20%.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 49 | 57 | 63 | 15 | 33 |
| Debt incl. finance leases | 30 | — | 2 | 2 | 2 |
| Net debt (negative means net cash) | −18 | — | −61 | −14 | −31 |
| Net debt to EBITDA | −0.5x | — | −1.0x | −0.2x | −0.4x |
| Debt to equity | 0.3x | — | 0.0x | 0.0x | 0.0x |
| Interest coverage | 2.3x | 51.1x | 76.7x | 28.5x | 58.7x |
| Current ratio | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Quick ratio | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
Cash flow
Projections
Project IBEX's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
What IBEX says to expect
- Fiscal 2027: revenue
Revenue is now expected to be in the range of $720 to $735 million, up 12-14% versus previous guidance of $700 to $715 million for 9-11% growth.
- Fiscal 2027: adjusted EBITDA
Adjusted EBITDA is now expected to be in the range of $96 to $99 million, up 17-20% versus previous guidance of $90 to $94 million for 9-14% growth.
- Fiscal 2027: capital expenditures
Capital expenditures for the year are expected to be approximately $30 million, at the high end of the previous $25 to $30 million range given the increased growth expectations.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought IBEX shares on the open market, and 11 insiders sold $7.7 million, $2.3 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | David Martin AfdahlChief Operating Officer | Sold | 28,319 | $56.35 | $1.6 million | Form 4 |
| Nov 13, 2026 | Julie K CasteelChief Sales/Marketing Officer | Sold | 3,200 | $56.70 | $181,448 | Form 4 |
| Sep 25, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold plan | 5,000 | $45.02 | $225,100 | Form 4 |
| Sep 16, 2026 | Paul Joseph InsonChief People Officer | Sold | 2,500 | $40.07 | $100,175 | Form 4 |
| Sep 16, 2026 | Christina Alice Trofimuk-O'ConnorChief Legal Officer | Sold | 2,376 | $39.34 | $93,472 | Form 4 |
| Sep 15, 2026 | Robert Thomas DechantChief Executive Officer, Director | Sold | 25,000 | $39.99 | $999,750 | Form 4 |
| Sep 15, 2026 | Julie K CasteelChief Sales/Marketing Officer | Sold | 17,474 | $40.41 | $706,124 | Form 4 |
| Sep 15, 2026 | Christina Alice Trofimuk-O'ConnorChief Legal Officer | Sold | 7,500 | $40.30 | $302,250 | Form 4 |
| Sep 15, 2026 | Mingzhe ZhuangDirector | Sold | 5,522 | $40.10 | $221,432 | Form 4 |
| Sep 15, 2026 | Daniella Ballou-AaresDirector | Sold | 1,500 | $40.29 | $60,435 | Form 4 |
| Sep 14, 2026 | David Martin AfdahlChief Operating Officer | Sold plan | 10,819 | $40.07 | $433,517 | Form 4 |
| Sep 14, 2026 | Paul Joseph InsonChief People Officer | Sold plan | 2,274 | $40.00 | $90,960 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 | FY26 |
|---|---|---|---|
| Piotroski F-score | — | 6 of 8 | 8 of 8 |
| Rule of 40 | 2.5% | 14.7% | 20.2% |
| Altman Z'' | 4.57 | 4.05 | 5.24 |
| Accruals ratio | −0.8% | −3.1% | −4.3% |
The nine F-score tests
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | — | Fail | Pass |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | — | 6 of 8 | 8 of 8 |
Compare
Put IBEX side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| IBEX | FY26 | 15.4% | 8.5% | 4.8% | 36.1% | −0.4x | 8 | |
| Verra Mobility | FY25 | 11.4% | 24.4% | 14.0% | 13.5% | 2.7x | 7 | Compare |
| EXL | FY25 | 13.6% | 15.0% | 14.3% | 28.4% | −0.1x | 8 | Compare |
| TTEC | FY25 | −3.2% | −5.5% | 3.9% | — | — | — | Compare |
| Conduent | FY25 | −9.4% | — | −4.3% | −7.8% | 5.5x | 3 | Compare |
9 years of figures
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 342 | 368 | 405 | 444 | 494 | 523 | 509 | 558 | 644 |
| Revenue growth | — | 7.7% | 10.0% | 9.5% | 11.2% | 6.0% | −2.8% | 9.8% | 15.4% |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — |
| Operating income | −18 | 7 | 20 | 17 | 21 | 40 | 39 | 47 | 55 |
| Net income | −16 | 11 | 8 | 13 | 22 | 32 | 34 | 37 | 46 |
| Diluted EPS (US$) | −1.42 | 0.00 | 0.00 | 0.71 | 1.15 | 1.67 | 1.84 | 2.36 | 3.13 |
| Diluted shares (millions) | 11 | 12 | 13 | 18 | 19 | 19 | 18 | 16 | 15 |
| Cash flow | |||||||||
| Cash from operations | −6 | 2 | 52 | 16 | 40 | 42 | 36 | 46 | 59 |
| Capital expenditure | 5 | 6 | 4 | 21 | 26 | 19 | 9 | 18 | 28 |
| Free cash flow | −11 | −3 | 47 | −5 | 14 | 23 | 27 | 27 | 31 |
| Dividends paid | 0 | 2 | 0 | 4 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 6 | 0 | 0 | 3 | 0 | 22 | 78 | 14 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 9 | 5 | 0 | 5 | 2 | 5 | 4 | 5 | 8 |
| Balance sheet at fiscal year end | |||||||||
| Cash and short-term investments | 14 | 9 | 22 | 58 | 49 | 57 | 63 | 15 | 33 |
| Debt incl. finance leases | — | 55 | 37 | 33 | 30 | — | 2 | 2 | 2 |
| Total assets | — | 188 | 195 | 274 | 294 | 293 | 294 | 273 | 309 |
| Total liabilities | — | 180 | 179 | 194 | 181 | 143 | 128 | 139 | 139 |
| Shareholders' equity | 26 | 9 | 19 | 95 | 114 | 150 | 166 | 134 | 170 |
| Margins and ratios | |||||||||
| Gross margin | — | — | — | — | — | — | — | — | — |
| Operating margin | −5.2% | 1.9% | 4.8% | 3.8% | 4.2% | 7.7% | 7.8% | 8.3% | 8.5% |
| Net margin | −4.6% | 3.0% | 1.9% | 3.0% | 4.3% | 6.0% | 6.6% | 6.6% | 7.2% |
| Free cash flow margin | −3.2% | −0.9% | 11.7% | −1.1% | 2.9% | 4.4% | 5.3% | 4.9% | 4.8% |
| Rule of 40 (growth + FCF margin) | — | 6.7% | 21.7% | 8.4% | 14.1% | 10.4% | 2.5% | 14.7% | 20.2% |
| Return on capital | — | — | 34.9% | 33.7% | 30.0% | — | — | 33.2% | 36.1% |
| Return on equity | — | — | 56.8% | 23.1% | 20.6% | 24.0% | 21.3% | 24.6% | 30.4% |
| Return on assets | — | — | 4.0% | 5.6% | 7.5% | 10.8% | 11.5% | 13.0% | 15.9% |
| Net debt to EBITDA | — | 1.7x | 0.3x | −0.8x | −0.5x | — | −1.0x | −0.2x | −0.4x |